Brief: Oasmia Q1 Operating Loss Narrows To SEK 40.8 Mln

Vivesto AB

27/05/2021 07:09

May 27 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * INTERIM REPORT FOR THE PERIOD JANUARY 1, 2021 – MARCH 31,
2021
    * Q1 CONSOLIDATED NET SALES AMOUNTED TO TSEK 37 (201,220)
    * Q1 OPERATING LOSS WAS TSEK -40,843 (128,607)

Source text for Eikon:  ID:nMFN4BDKZP 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))